Agency approved Molnupiravir one day after approving Pfizer’s antiviral pill Paxlovid.
(Matthew Perrona – AP) U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.
The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer….
That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.
The conservative voice and Christian content are being silenced more and more. CRN offers a lifeline to conservative people of faith who are disgusted with Facebook, Twitter and the MSM for failing to report, even blocking, important news stories that don’t comport with the far left’s narrative. We urge you to sign up to receive our FREE need to read articles. NO ADS! NO VIDEOS! NO POPUPS! JUST STRAIGHT NEWS.
Join Marsha West on MeWe